Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia

Background: Bedaquiline is one of the core drugs used to treat multidrug-resistant TB (MDR-TB). Delamanid is one of the companion drugs in group C which is used to complete the treatment regimen when drugs in groups A and B can not be used. This study was conducted to analyze the efficacy and safety...

Full description

Bibliographic Details
Published in:International Journal of Mycobacteriology
Main Authors: Soedarsono Soedarsono, Ni Made Mertaniasih, Tutik Kusmiati, Ariani Permatasari, Susi Subay, Suko Hari Adiono
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-06-01
Subjects:
acid-fast bacilli conversion
bedaquiline
delamanid
individual regimen
multidrug-resistant tuberculosis
mycobacterium tuberculosis culture conversion
qtc interval prolongation
Online Access:https://journals.lww.com/10.4103/ijmy.ijmy_88_24

Internet

https://journals.lww.com/10.4103/ijmy.ijmy_88_24

Similar Items